Cargando…
Changes in BMD T-score from pre-to post-treatment with biosimilar teriparatide: A single-arm, multi-center study
INTRODUCTION: Teriparatide is a recombinant analog of the parathyroid hormone and an anabolic treatment modality for osteoporosis. This study aimed to evaluate the effectiveness of biosimilar teriparatide (CinnoPar®, CinnaGen Co., Iran) in osteoporotic patients after at least one year of treatment....
Autores principales: | Soroush, Mohsen G., Kheirandish, Maryam, Soroosh, Soosan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245092/ https://www.ncbi.nlm.nih.gov/pubmed/37293390 http://dx.doi.org/10.1016/j.bonr.2023.101689 |
Ejemplares similares
-
Treatment of osteoporotic fractures in alkaptonuria by teriparatide stimulates bone formation and decreases fracture rate – A report of two cases
por: Ranganath, L.R., et al.
Publicado: (2021) -
In silico Analysis of Pasteurella multocida PlpE Protein Epitopes As Novel Subunit Vaccine Candidates
por: Mostaan, Saied, et al.
Publicado: (2021) -
Synergistic Effect of Vitamin C with Cisplatin for Inhibiting Proliferation of Gastric Cancer Cells
por: Ghavami, Ghazaleh, et al.
Publicado: (2020) -
Evaluation of cortical bone remodeling in canines treated with daily and weekly administrations of teriparatide by establishing AI-driven morphometric analyses and GIS-based spatial mapping
por: Hoshi-Numahata, Marie, et al.
Publicado: (2023) -
A phase III, randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA®) to the reference product (Humira®) in patients with active rheumatoid arthritis
por: Jamshidi, Ahmadreza, et al.
Publicado: (2017)